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scales (Shaw et al., 2010). This is changing the way we study the func-
tional mechanisms of life systems, and the integration of structural
data, molecular biology experiments and computational simulations
will be essential for a full understanding of the complex biological and
pathological processes that occur in cells. As 2013 Novel Laureate in
ChemistryMichael Levitt said in 1998, “Computing has changed biologyThere is increasing evidence of the important role of innate immune
system in tumor surveillance (Vesely et al., 2011). The spontaneous im-
mune response of T cells against tumors has a powerful prognostic value
and can contribute to tumor control in patients. Indeed, T cell-based im-
munotherapies have shown to be effective in a variety of human cancers
(Schumacher and Schreiber, 2015). A major player in this innate im-
mune response is the stimulator of interferon genes (STING) protein,
which is activated when a cell is infected by pathogens (Tanaka and
Chen, 2012) or in the presence of tumor-derived cytosolic DNA (Woo
et al., 2014). This pathway is critical for spontaneous T cell priming
against tumors. Thus, understanding this mechanism at molecular
level can be of paramount importance for improving prognosis and
tumor-growth control in patients, as well as for developing new bio-
markers and therapeutic vaccines. The activation of STING induces
IFN-β production, and occurs after binding cyclic GMP-AMP (cGAMP),
derived frompathogen or host-damaged cells. After that, the C-terminal
tail (CTT) of STING is phosphorylated by TANK-binding kinase 1 (TBK1).
Small-molecule ligands of STING are thus potential candidates for anti-
cancer drugs or vaccine adjuvants. There are several available structures
of cGAMP bound to STING, but none of them include the functionally
relevant CTT segment, probably because of its ﬂexibility. As a conse-
quence, the structural changes that ligands such as cGAMP induce in
STING CTT to make it phosphorylatable by TBK1 are not fully under-
stood. The limitations of structure determination and the rather static
picture that most of the currently available structural techniques pro-
vide are hampering the design of new STING ligands.
In this context, computational methods such as molecular dynamics
(MD) simulations can provide a detailed description of the thermody-
namic properties and time-dependent phenomena of proteins
(McCammon et al., 1977). Thanks to the exponential growth in compu-
tational power, MD simulations are currently applied to study dynamicm.2016.05.039.
. This is an open access article underevents in proteins and other biomolecules at biologically relevant time-
forever; most biologists just don't know it yet”.
In EBioMedicine, Tsuchiya et al. (2016) identify the mechanism of
STING activation at molecular level by using a combination of
computational simulations and experimental approaches. They have
studied the conformational effect induced by the ligand cGAMP on the
ﬂexible C-terminal tail (CTT) of the innate immune protein STING, by
molecular dynamics (MD) simulations. The MD trajectories used in
their study were long enough (1 μs) to observe the effects of cGAMP
ligand binding on the ﬂexibility of the CTT region. The ﬁndings from
the molecular dynamics analyses were conﬁrmed by molecular biology
experiments, which allowed them to propose a new mechanism for
STING activation.
They found that in cGAMP-bound STING: i) the closed-Lid conforma-
tion was kept throughout the simulation, which was previously shown
as essential for IFN-β activity; (Gao et al., 2014) ii) the end of CTTmoved
onto the Lid; and iii) the CTT region acquired a transient but deﬁned β-
sheet structure, which resembles the structure of the SER-rich region of
IRF3 also phosphorylated by TBK1 (Takahasi et al., 2010). The impor-
tance of the residues forming the β-sheet in CTT for the activation of
IFN-β was proved by site-directed mutagenesis experiments.
The ﬁndings in Tsuchiya and colleagues' study open the door for fu-
ture in silico screening studies in search of candidatemolecules for ther-
apeutic intervention. As they propose in their work, attention must be
paid not only to the ligand-binding domain of STING but also to the ef-
fect of ligand binding in the ﬂexible CTT region. The proposed model
based onMD simulations can help to plan new virtual and experimental
screening schemes in search of potent STING ligands that can promote
IFN-β activity. This could lead to new anti-tumor therapeutic strategies
through the enhancement of spontaneous immune response in
patients.
Tsuchiya and colleagues' study is a nice example of how the combi-
nation of computational simulations and molecular biology experi-
ments can contribute to improve our understanding of relevant
problems in biomedicine, such as the natural immune response against
tumors.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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